![]() |
Email:
|
maria.kacirova@upjs.sk |
Homepage:
|
https://www.upjs.sk/LF/zamestnanec/maria.kacirova | |
Faculty:
|
LF UPJŠ
-
Pavol Jozef Šafárik University in Košice Faculty of Medicine
|
|
Department:
|
ULBF
-
Department of Medical and Clinical Biophysics
|
|
Office:
|
||
Phone:
|
+421 55 234 3560 | |
ORCID ID:
|
0000-0002-3049-9442 |
Selected publications
|
ADC - Kacírová M., Bober P., Alexovič M., Tomková Z., Tkáčiková S., Talian I., Mederová L., Bérešová D., Tóth R., Andrašina I., Kožlejová Z., Kilík R., Divin R., Sabo J.: Differential urinary proteomic analysis of endometrial cancer. In: Physiological research. - ISSN 0862-8408. - Vol. 68, Supplement 4 (2019), p. S483-S490. 10.33549/physiolres.934375 DOI; CCC; SCOPUS; WOS CC; 2019 JIF=1,655; 2019 Q4 (Physiology) SCIE, cited: 2x |
ADC - Laputková G., Bencková M., Alexovič M., Schwartzová V., Talian I., Sabo J.: Proteomic and bioinformatics analysis of human saliva for the dental-risk assessment. In: Open Life Sciences. - ISSN 2391-5412. - Vol. 12 (2017), p. 248 - 265. CCC; 2017 JIF=0,764; 2017 Q4 (Biology) SCIE, cited: 1x |
ADC - Bober P., Alexovič M., Talian I., Tomková Z., Kožlejová Z., Bencková M., Andrašina I., Ciccocioppo R., Petrovic D., Adamek M., Kružliak P., Sabo J.: Proteomic analysis of the vitamin C effect on the doxorubicin cytotoxicity in the MCF 7 breast cancer cell line. In: Journal of Cancer research and Clinical Oncology. - ISSN 1432-1335. - Vol. 143, no. 1 (2017), p. 35 - 42. CCC; 2017 CCC JIF=3,282; 2017 Q2 (Oncology) SCIE, cited: 15x |
ADC - El-Hawli A., Qaradakhi T., Hayes A., Rybalka E., Smith R., Caprnda M., Opatrilová R., Gazdíková K., Bencková M., Kružliak P., Zulli A.: IRAP inhibition using HFI419 prevents moderate to severe acetylcholine mediated vasoconstriction in a rabbit model. In: Biomedicine and Pharmacotherapy. - ISSN 0753-3322. - Vol. 86 (2017), p. 23 - 26. CCC; 2017 CCC, cited: 5x |
ADC - Chmelová M., Géci I., Talian I., Bober P., Bačenková D., Rosocha J., Urdzík P., Bencková M., Semančíková E., Kružliak P., Sabo J.: Proteomic analysis of chorion-derived mesenchymal stem cells: Combination of 2D nano-HPLC in tandem with ESI mass spectrometry. In: Chromatographia. - ISSN 0009-5893. - Vol. 80, no. 2 (2017), p. 201 - 207. CCC; 2017 CCC JIF=1,401; 2017 Q3 (Chemistry, Analytical), Q4 (Biochemical Research Methods) SCIE, cited: 1x |
Selected projects
|
Co-investigator of subactivity 1.2: Výskumná agentúra MŠ SR - project: AKARDIO COVID-19: Analysis of cardiovascular and immune response of COVID-19 patiens after recovery with focus on research of new diagnostic markers and therapeutic approaches Principal investigator of subactivity 1.2: doc. RNDr. Ján Sabo, CSc., mim. prof. (Analysis of proteome cell changes of the immune system of COVID-19 patients after recovery) Brief description of the project: Blood provides a dynamic reflection of physiological and pathological condition. Leukocytes constantly perfusing the human body encompass a protein-rich information encoded in quantity and quality of proteins. Pathogenesis and progression of infectious disease are associated with leukocyte-derived proteins. Analysis of proteome cell changes of leukocytes after SARS-CoV-2 infection may be utilized on evaluation of the efficacy of new developed vaccines. |
Projects
|
Co-investigator of subactivity 1.2: Výskumná agentúra MŠ SR - project: AKARDIO COVID-19: Analysis of cardiovascular and immune response of COVID-19 patiens after recovery with focus on research of new diagnostic markers and therapeutic approaches Principal investigator of subactivity 1.2: doc. RNDr. Ján Sabo, CSc., mim. prof. (Analysis of proteome cell changes of the immune system of COVID-19 patients after recovery) Brief description of the project: Blood provides a dynamic reflection of physiological and pathological condition. Leukocytes constantly perfusing the human body encompass a protein-rich information encoded in quantity and quality of proteins. Pathogenesis and progression of infectious disease are associated with leukocyte-derived proteins. Analysis of proteome cell changes of leukocytes after SARS-CoV-2 infection may be utilized on evaluation of the efficacy of new developed vaccines.
|